Skip to main content
Premium Trial:

Request an Annual Quote

Manuel Glynias, Bill Blake, Ed Zander, Richard Woychik

Premium

NetGenics founder and former CEO Manuel Glynias has left Lion Biosciences, where he was serving as senior vice president for strategic planning following Lion’s acquisition of Netgenics in January.

A Lion spokesperson said Glynias’ departure was a “friendly and mutual decision.”

 

Bill Blake, formerly vice president of high performance technical computing at Compaq (now Hewlett-Packard), will be leaving the company at the end of June. He will join Framingham, Mass.-based database and data-mining startup Netezza as senior vice president of product development. “One of my goals is to help them bring their products to the bioinformatics marketplace,” said Blake of his new employer.

In May, Ed Zander, president and COO of Sun Microsystems, joined Netezza’s board of directors.

 

Richard Woychik, currently CSO of Hayward, Calif.-based Lynx Therapeutics, has been tapped as the new director of the Jackson Laboratory in Bar Harbor, Maine. He will assume his new role at the Jackson Lab in August and will continue to serve on Lynx’s board of directors.

Filed under

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.